Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals had revenue of $50.03M in the quarter ending September 30, 2024, with 613.22% growth. This brings the company's revenue in the last twelve months to $138.16M, up 1,523.50% year-over-year. In the year 2023, Avadel Pharmaceuticals had annual revenue of $27.96M.

• Revenue (ttm): $138.16M
• Revenue Growth: +1,523.50%
• P/S Ratio: 6.98
• Revenue / Employee: $897,143
• Employees: 154
• Market Cap: 993.49M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	27.96M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	22.33M	-36.88M	-62.28%
Dec 31, 2019	59.22M	-44.05M	-42.66%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.